BioCentury
ARTICLE | Financial News

GlobeImmune raises $41.2 million

September 27, 2007 12:19 AM UTC

GlobeImmune (Louisville, Colo.) raised $41.2 million in a series C round led by Wexford Capital. Other new investors Celgene (CELG); Mellon Family Investment Company; Richard King Mellon Foundation; Eminent Venture Capital Corp.; Boston Life Science Venture Corp.; and WRF Capital joined existing investors HealthCare Ventures; Morgenthaler Ventures; Sequel Venture Partners; Lilly Ventures; Medica Venture Partners; Adams Street Partners; Biogen Idec (BIIB); Pac-Link BioVentures; China Investment and Development; Yasuda Enterprise Development; Partners Healthcare; and GC&H Investments. Aquilo Partners was the placement agent. Wexford's Paul Mieyal will join the company's board. ...